Unexplained Weight Gain Blood Test UK: 10 Biomarkers Your GP Might Miss

When the scales move and your habits haven't changed

You're eating the same food, exercising as much as before, sleeping roughly the same hours — and yet the weight is creeping up. Half a stone over six months. A full stone over a year. Clothes that no longer fit. The frustration is compounded by the fact that nobody can tell you why.

Your GP might suggest “eating less and moving more” or run a basic thyroid check that comes back “normal”. But “normal” on an NHS blood test does not mean optimal. The NHS reference range for TSH, for example, spans 0.27–4.2 mIU/L — a range so wide that someone at 3.8 (sluggish thyroid, clinically significant for many people) sits alongside someone at 1.2 (genuinely healthy) under the same label.

Behind almost every case of unexplained weight gain, there is a metabolic or hormonal signal that a targeted blood test can detect. The NICE NG220 guidelines on obesity management acknowledge that “secondary causes” including thyroid dysfunction, Cushing's syndrome, PCOS, and certain medications should be considered before attributing weight gain solely to lifestyle.

This guide covers the ten biomarkers most frequently implicated in unexplained weight gain, explains what each one does, shows you where the NHS reference range hides the grey zone, and gives you evidence-based next steps for each result pattern.

The full picture

10 blood markers that explain unexplained weight gain

These are the markers a comprehensive weight-gain investigation should include. Your GP will typically check one or two. A full private panel checks all ten.

Sources: NHS (thyroid), NICE NG17 (type 2 diabetes prevention), Lancet Diabetes & Endocrinology (T4DM trial), BMJ (vitamin D and metabolic health).

Marker 1 of 10

Thyroid function: the metabolic thermostat

Your thyroid gland sets the pace at which your body burns calories at rest. Even a mildly underactive thyroid — clinically called subclinical hypothyroidism — can reduce your basal metabolic rate by 5–15%, which over a year translates to 5–10 kg of unexplained weight gain without any change in diet or exercise.

The problem is that the NHS typically only tests TSH. TSH is a pituitary hormone that signals the thyroid, but it doesn't tell you how much active hormone your thyroid is actually producing. Free T4 (the storage hormone) and particularly Free T3 (the active hormone that enters cells and drives metabolism) are the markers that explain whether your thyroid output is genuinely adequate.

Research published in The Journal of Clinical Endocrinology & Metabolism found that a TSH above 2.5 mIU/L is associated with higher BMI, higher total cholesterol, and lower metabolic rate compared with a TSH between 0.5 and 2.5. If your TSH is 3.5 and your GP says “normal”, your metabolism may be running 10% slower than someone with the same age, sex, and activity level.

What to do if your thyroid is borderline: Retest in 8–12 weeks. If TSH remains above 2.5 with symptoms (fatigue, cold intolerance, dry skin, constipation alongside weight gain), the NICE CKS hypothyroidism pathway recommends your GP considers a trial of levothyroxine, particularly if thyroid antibodies (TPO-Ab) are also positive.

Marker 2 of 10

Insulin resistance: the hidden driver of central weight gain

If your weight gain is concentrated around your waist — visceral fat, the kind that wraps around your internal organs — insulin resistance is the most likely metabolic explanation. Insulin is a storage hormone: when cells become resistant to it, the pancreas produces more. Chronically elevated insulin drives fat into storage and makes it physiologically harder to release, even during calorie restriction and exercise.

The Diabetes Prevention Programme (DPP) — the largest lifestyle-intervention trial ever conducted — showed that identifying insulin resistance early and intervening with structured lifestyle changes reduced progression to type 2 diabetes by 58%. But here is the catch: the NHS does not routinely test fasting insulin.

The standard NHS metabolic check is HbA1c, which measures average blood sugar over three months. HbA1c is useful but it is a lagging indicator — by the time HbA1c rises into the prediabetic range (42–47 mmol/mol), insulin resistance has typically been present for 5–10 years. Fasting insulin rises first, often while HbA1c is still reassuringly “normal”.

What to do if insulin is high: The evidence base for reversing insulin resistance through lifestyle is strong. NICE NG17 recommends a structured programme of resistance training (which directly improves insulin sensitivity in muscle), reduction of refined carbohydrates, and 150 minutes of moderate-intensity exercise per week. Retest fasting insulin and HbA1c at 12 weeks to track response.

Marker 3 of 10

Testosterone: the muscle-fat ratio regulator

Low testosterone is one of the most underdiagnosed contributors to weight gain in both men and women. In men, testosterone directly regulates lean muscle mass: less testosterone means less metabolically active tissue, which means a lower basal metabolic rate and a shift toward fat storage — particularly visceral fat around the abdomen.

The Testosterone for Diabetes Mellitus (T4DM) trial published in The Lancet Diabetes & Endocrinology followed 1,007 men with low testosterone and prediabetes for two years. The testosterone-treated group saw a 40% reduction in type 2 diabetes incidence compared with placebo, driven largely by reductions in visceral fat and improvements in insulin sensitivity.

In women, testosterone is equally important for body composition but rarely checked. Low testosterone in women is associated with reduced muscle tone, increased fatigue, and difficulty maintaining weight after the age of 35 — particularly around perimenopause when both testosterone and oestrogen decline.

What to do if testosterone is low: In men, if total testosterone is below 12 nmol/L with symptoms, your GP should investigate further per BSSM 2022 guidelines. In women, testosterone testing is relevant during perimenopause investigations per NICE NG23 (menopause). Resistance training, adequate sleep (7–9 hours), and vitamin D optimisation all support healthy testosterone levels in both sexes.

Marker 4 of 10

Cortisol: the stress-fat connection

Cortisol is your body's primary stress hormone. Acute cortisol spikes are normal and healthy. The problem begins when cortisol stays chronically elevated — due to sustained psychological stress, poor sleep, overtraining, or rarely an adrenal tumour (Cushing's syndrome).

Chronically elevated cortisol promotes visceral fat deposition, increases appetite for high-calorie foods, breaks down muscle tissue (reducing metabolic rate), and impairs insulin sensitivity — a quadruple hit to body composition. The weight gain pattern is characteristic: face, neck, and abdomen expand while arms and legs may appear relatively thinner.

A systematic review in Obesity (2017) confirmed a significant positive association between long-term cortisol exposure and BMI, waist circumference, and visceral fat area.

What to do if cortisol is high: If morning fasting cortisol is above 550 nmol/L, your GP should investigate for Cushing's syndrome (24-hour urinary cortisol, late-night salivary cortisol, or dexamethasone suppression test). For chronically elevated but sub-Cushing's cortisol, evidence supports stress-reduction interventions: adequate sleep, reducing caffeine intake (particularly after 2pm), structured exercise (moderate, not excessive), and in some cases ashwagandha supplementation (300–600 mg/day KSM-66 extract).

Markers 5 & 6

Oestradiol and SHBG: the fat distribution regulators

Oestradiol and SHBG (sex hormone-binding globulin) work together to regulate fat distribution. In men, excess oestradiol — often produced by the aromatase enzyme in visceral fat tissue — creates a feedback loop: more fat produces more oestradiol, which signals the body to store more fat, particularly around the chest, hips, and abdomen.

SHBG acts as a regulator: it binds both testosterone and oestradiol, controlling how much of each hormone is “free” and active. Low SHBG is strongly associated with insulin resistance, metabolic syndrome, and visceral obesity. A study in Diabetes Care found that low SHBG is an independent predictor of type 2 diabetes risk in both men and women, even after adjusting for BMI, insulin, and glucose.

In women approaching or during perimenopause, declining oestradiol shifts fat distribution from hips and thighs (subcutaneous) to the abdomen (visceral). This is not a cosmetic issue — visceral fat is metabolically active, producing inflammatory cytokines that further worsen insulin resistance. Checking oestradiol, testosterone, and SHBG together provides the hormonal context that TSH and HbA1c alone cannot.

Marker 7 of 10

Vitamin D: the deficiency that makes everything harder

Vitamin D deficiency affects an estimated 1 in 5 UK adults (below 25 nmol/L) according to the SACN 2016 report, and many more sit in the insufficient range (25–50 nmol/L). The relationship between vitamin D and weight is bidirectional: deficiency impairs insulin signalling and fat metabolism, while excess body fat sequesters vitamin D in adipose tissue, reducing circulating levels further.

A meta-analysis published in The BMJ found that vitamin D supplementation in deficient individuals was associated with modest improvements in insulin sensitivity and inflammatory markers, though not with significant weight loss alone. The clinical takeaway: vitamin D deficiency doesn't cause weight gain by itself, but it amplifies every other metabolic driver on this list.

What to do: The NHS recommends 10 µg (400 IU) daily as a minimum for all UK adults from October to March. If your level is below 50 nmol/L, your GP may recommend a loading dose of 1,000–4,000 IU daily for 8–12 weeks, then retesting. Optimal for metabolic health is typically 75–125 nmol/L.

Marker 8 of 10

hs-CRP: the inflammation-obesity feedback loop

High-sensitivity CRP is the most widely validated marker of systemic inflammation. In the context of weight gain, it matters because visceral fat is not inert storage — it is an active endocrine organ that produces inflammatory cytokines (TNF-α, IL-6, MCP-1). These cytokines elevate hs-CRP and simultaneously worsen insulin resistance, creating a self-reinforcing loop: more fat → more inflammation → worse insulin sensitivity → more fat storage.

The American Heart Association classifies hs-CRP below 1.0 mg/L as low risk, 1.0–3.0 as moderate, and above 3.0 as high risk. In the context of weight gain investigation, hs-CRP above 3.0 alongside elevated fasting insulin or HbA1c strongly suggests an inflammatory-metabolic driver.

What to do: Anti-inflammatory dietary patterns (Mediterranean diet) have the strongest evidence base. A landmark study in The New England Journal of Medicine (PREDIMED) showed that a Mediterranean diet supplemented with olive oil or nuts significantly reduced hs-CRP and cardiovascular events. Omega-3 fatty acids (2–4 g/day EPA+DHA), regular exercise, and adequate sleep also lower hs-CRP.

The gap

NHS vs private: what gets checked and what gets missed

When you go to your GP with unexplained weight gain, the standard workup typically includes TSH, HbA1c, and sometimes a lipid panel and liver function tests. This covers three of the ten markers above. The seven markers most commonly missed are the ones that explain the majority of metabolically driven weight gain:

The NHS checks 3 of 11. A comprehensive private panel checks all 11. That gap is the difference between “your thyroid is fine, try eating less” and “your fasting insulin is elevated, your Free T3 is at the bottom of the range, and your SHBG is low — here are three specific things to address.”

What your results mean

Five result patterns we see in unexplained weight gain

After reviewing thousands of blood test results, clear patterns emerge. Most people with unexplained weight gain fit one of these five profiles. Some people have two or three overlapping.

When to see your GP urgently

Red flags: weight gain that needs immediate investigation

Most unexplained weight gain has a metabolic or hormonal cause that responds to targeted intervention. But certain patterns require urgent medical attention:

• !Rapid weight gain (more than 2 kg in a week) with swelling — may indicate fluid retention from heart, kidney, or liver dysfunction
• !Weight gain with moon face, purple stretch marks, thin skin, and easy bruising — Cushing's syndrome pattern, needs urgent cortisol investigation
• !Weight gain with a neck lump, difficulty swallowing, or voice changes — thyroid nodule or goitre, needs ultrasound
• !Weight gain with new-onset severe headaches or visual disturbance — pituitary tumour can affect multiple hormone axes
• !Weight gain after starting a new medication (corticosteroids, antipsychotics, certain antidepressants, insulin, beta-blockers) — discuss alternatives with your prescriber
• !Unexplained weight gain in a child or adolescent — paediatric endocrine referral needed

If any of these apply, see your GP before ordering a private blood test. They may need to arrange imaging, specialist referral, or urgent endocrine investigation.

Two approaches

GP pathway vs comprehensive private panel

Which test to choose

Recommended panels for unexplained weight gain

The right panel depends on what you suspect is driving the weight gain:

Evidence base

Sources and further reading

• ●NICE NG220: Obesity — identification, assessment and management — UK clinical guideline on secondary causes of weight gain
• ●NICE NG17: Type 2 diabetes prevention — DPP trial evidence on insulin resistance intervention
• ●JCEM (2012): TSH within the reference range is associated with BMI — evidence that TSH >2.5 is associated with higher body weight
• ●Lancet Diabetes & Endocrinology: T4DM trial — testosterone treatment reduced type 2 diabetes incidence by 40% in men with low T
• ●BMJ (2021): Vitamin D and metabolic health — meta-analysis on vitamin D, insulin sensitivity, and inflammation
• ●Diabetes Care (2010): Low SHBG and type 2 diabetes risk — SHBG as independent predictor of metabolic syndrome
• ●Obesity (2017): Cortisol and adiposity — systematic review of long-term cortisol exposure and body composition
• ●SACN (2016): Vitamin D and health — UK-specific vitamin D deficiency prevalence and recommendations
• ●NHS: Underactive thyroid (hypothyroidism) — patient information on symptoms and treatment
• ●NEJM (2018): PREDIMED trial — Mediterranean diet, inflammation, and cardiovascular outcomes
• ●BSSM (2022): Testosterone deficiency guidelines — UK guidelines on investigation and management of male hypogonadism

Common questions

Unexplained weight gain blood test FAQs